Cargando…

Serglycin Is Involved in TGF-β Induced Epithelial-Mesenchymal Transition and Is Highly Expressed by Immune Cells in Breast Cancer Tissue

Serglycin is a proteoglycan highly expressed by immune cells, in which its functions are linked to storage, secretion, transport, and protection of chemokines, proteases, histamine, growth factors, and other bioactive molecules. In recent years, it has been demonstrated that serglycin is also expres...

Descripción completa

Detalles Bibliográficos
Autores principales:	Tellez-Gabriel, Marta, Tekpli, Xavier, Reine, Trine M., Hegge, Beate, Nielsen, Stephanie R., Chen, Meng, Moi, Line, Normann, Lisa Svartdal, Busund, Lill-Tove R., Calin, George A., Mælandsmo, Gunhild M., Perander, Maria, Theocharis, Achilleas D., Kolset, Svein O., Knutsen, Erik
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Oncology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9047906/ https://www.ncbi.nlm.nih.gov/pubmed/35494005 http://dx.doi.org/10.3389/fonc.2022.868868

Ejemplares similares

Serglycin in Quiescent and Proliferating Primary Endothelial Cells
por: Reine, Trine M., et al.
Publicado: (2015)

Serglycin is part of the secretory repertoire of LPS-activated monocytes
por: Kolseth, Ingrid Benedicte M, et al.
Publicado: (2015)

Serglycin: At the Crossroad of Inflammation and Malignancy
por: Korpetinou, Angeliki, et al.
Publicado: (2014)

Molecular Interactions Stabilizing the Promatrix Metalloprotease-9·Serglycin Heteromer
por: Dawadi, Rangita, et al.
Publicado: (2020)

Increased Expression of Serglycin in Specific Carcinomas and Aggressive Cancer Cell Lines
por: Korpetinou, Angeliki, et al.
Publicado: (2015)

Serglycin Is Implicated in the Promotion of Aggressive Phenotype of Breast Cancer Cells
por: Korpetinou, Angeliki, et al.
Publicado: (2013)

Serglycin activates pro-tumorigenic signaling and controls glioblastoma cell stemness, differentiation and invasive potential
por: Manou, Dimitra, et al.
Publicado: (2020)

Differential expression of the miR-17-92 cluster and miR-17 family in breast cancer according to tumor type; results from the Norwegian Women and Cancer (NOWAC) study
por: Moi, Line, et al.
Publicado: (2019)

The effect of acute and long-term physical activity on extracellular matrix and serglycin in human skeletal muscle
por: Hjorth, Marit, et al.
Publicado: (2015)

Serglycin in human cancers
por: Li, Xin-Jian, et al.
Publicado: (2011)

Glucosamine exposure reduces proteoglycan synthesis in primary human endothelial cells in vitro
por: Reine, Trine M., et al.
Publicado: (2016)

miR-101-5p Acts as a Tumor Suppressor in HER2-Positive Breast Cancer Cells and Improves Targeted Therapy
por: Normann, Lisa Svartdal, et al.
Publicado: (2022)

Expression and function of the miR-143/145 cluster in vitro and in vivo in human breast cancer
por: Johannessen, Charles, et al.
Publicado: (2017)

Cohort profile: The Clinical and Multi-omic (CAMO) cohort, part of the Norwegian Women and Cancer (NOWAC) study
por: Delgado, André Berli, et al.
Publicado: (2023)

Serglycin as a potential biomarker for glioma: association of serglycin expression, extent of mast cell recruitment and glioblastoma progression
por: Roy, Ananya, et al.
Publicado: (2017)

Fibroblast miR-210 overexpression is independently associated with clinical failure in Prostate Cancer – a multicenter (in situ hybridization) study
por: Andersen, Sigve, et al.
Publicado: (2016)

MicroRNA in combination with HER2-targeting drugs reduces breast cancer cell viability in vitro
por: Normann, Lisa Svartdal, et al.
Publicado: (2021)

Current Status of Circulating Tumor Cells, Circulating Tumor DNA, and Exosomes in Breast Cancer Liquid Biopsies
por: Tellez-Gabriel, Marta, et al.
Publicado: (2020)

Targeting Serglycin Prevents Metastasis in Murine Mammary Carcinoma
por: Roy, Ananya, et al.
Publicado: (2016)

Cathepsin L promotes chemresistance to neuroblastoma by modulating serglycin
por: Du, Xiaohuan, et al.
Publicado: (2022)

High-throughput screen in vitro identifies dasatinib as a candidate for combinatorial treatment with HER2-targeting drugs in breast cancer
por: Normann, Lisa Svartdal, et al.
Publicado: (2023)

Serglycin proteoglycans limit enteropathy in Trichinella spiralis-infected mice
por: Roy, Ananya, et al.
Publicado: (2016)

The relationship between plasma serglycin levels and the diagnosis of diabetic retinopathy
por: Wang, Layi, et al.
Publicado: (2020)

The expression of the long NEAT1_2 isoform is associated with human epidermal growth factor receptor 2-positive breast cancers
por: Knutsen, Erik, et al.
Publicado: (2020)

Significance of serglycin and its binding partners in autocrine promotion of metastasis in esophageal cancer
por: Zhu, Yun, et al.
Publicado: (2021)

Serglycin induces osteoclastogenesis and promotes tumor growth in giant cell tumor of bone
por: He, Yunfei, et al.
Publicado: (2021)

Immunohistochemical expression of epithelial and stromal immunomodulatory signalling molecules is a prognostic indicator in breast cancer
por: Richardsen, Elin, et al.
Publicado: (2012)

Mediators Linking Maternal Weight to Birthweight and Neonatal Fat Mass in Healthy Pregnancies
por: Kristiansen, Oddrun, et al.
Publicado: (2021)

Editorial: Growth and Tissue Regeneration with focus on Proteoglycans
por: Pedersen, Mona Elisabeth, et al.
Publicado: (2023)

Serglycin promotes proliferation, migration, and invasion via the JAK/STAT signaling pathway in osteosarcoma
por: Lv, Bin, et al.
Publicado: (2021)

Intellectual disability and nutrition‐related health
por: Kolset, Svein O
Publicado: (2020)

The Prognostic Impact of TGF-β1, Fascin, NF-κB and PKC-ζ Expression in Soft Tissue Sarcomas
por: Valkov, Andrej, et al.
Publicado: (2011)

Chondroitin sulfate proteoglycan serglycin influences protein cargo loading and functions of tumor-derived exosomes
por: Purushothaman, Anurag, et al.
Publicado: (2017)

miR-26b-5p suppresses chemoresistance in breast cancer by targeting serglycin
por: Du, Qiwei, et al.
Publicado: (2021)

High expression of microRNA-126 relates to favorable prognosis for colon cancer patients
por: Selven, Hallgeir, et al.
Publicado: (2021)

Proteoglycans Determine the Dynamic Landscape of EMT and Cancer Cell Stemness
por: Karagiorgou, Zoi, et al.
Publicado: (2022)

Antirheumatic treatment is associated with reduced serum Syndecan-1 in Rheumatoid Arthritis
por: Deyab, Gia, et al.
Publicado: (2021)

Detection of MicroRNAs in Archival Cytology Urine Smears
por: Simonato, Francesca, et al.
Publicado: (2013)

Stage and tissue-specific prognostic impact of miR-182 in NSCLC
por: Stenvold, Helge, et al.
Publicado: (2014)

The blood transcriptome prior to ovarian cancer diagnosis: A case-control study in the NOWAC postgenome cohort
por: Jareid, Mie, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_ekncf7jivdl9e47c7jt9soas4q